
Scientists have developed a more precise genetic risk score to determine whether a person is likely to develop arrhythmia, which can lead to serious conditions such as atrial fibrillation or sudden cardiac death.

An international team of scientists has identified critical risk factors that could help predict sudden unexpected death in epilepsy, according to a study published in The Lancet.

Northwestern Medicine scientists have uncovered new insights into how the PAI-1 protein contributes to cardiovascular aging and how inhibiting PAI-1 may be a promising therapeutic approach for mitigating cardiovascular disease, according to recent findings published in The Journal of Clinical Investigation.

Northwestern scientists, clinicians and people living with ALS gathered to learn about the latest research and celebrate advancements in patient care during the 15th annual Les Turner Symposium on ALS held at Northwestern Memorial Hospital on November 3.

Northwestern Medicine scientists have uncovered how a specific type of cell in the inner ear plays a commanding role in shaping the cellular landscape of the organ responsible for hearing, according to a study published in Science Advances.

A Northwestern Medicine-led study has established the first pediatric-specific atlas of acute care regions across the United States, offering the clearest picture of how children access emergency and inpatient services to date, according to the study published in JAMA Pediatrics.

A new study shows that pancreatic tumors use a sugar-based disguise to hide from the immune system, and Northwestern scientists have also created an antibody therapy that blocks the “don’t-attack” signal.

A new Northwestern study has uncovered how a key disease protein drives overactive nerve cells in neurodegenerative diseases like ALS and frontotemporal dementia.

A Northwestern Medicine-led study has identified mutations in the gene CEP76 as a new cause of ciliopathies, shedding light on a complex group of disorders that affect multiple body systems, according to a study published in Science Advances.

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and chemotherapy resistance in ovarian cancer cells, findings that may inform new targeted treatment approaches that inhibit this process and improve patient outcomes, according to a recent study published in The Journal of Clinical Investigation.